X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Stock markets extend losses 
(Thu, 29 Jan 11:30 am) 
 
After starting today's session on a negative note, Indian Indices have continued to trade in the red. Heavyweights in Sensex are trading weak with stocks from the IT and Metal space witnessing selling pressure. However, stocks from the capital goods and oil and gas sector are trading strong.

The BSE-Sensex is trading down by 155 points and NSE-Nifty is trading down by 32 points. BSE Mid Cap and BSE Small Cap indices are trading up by 0.23% and 0.28% respectively. The rupee is trading at 61.41 to the US dollar.

Indian pharmaceutical stocks are trading mixed today. Elder pharma and Indoco remedies are the leading gainers while Torrent pharma and Sun pharma are the leading losers. Ranbaxy has reported a loss of Rs 10.29 bn for the 2014 December quarter compared to Rs 1.5 bn in the year ago period. It's the company's biggest quarterly loss. Net sales fell 9.5% to Rs 26.18 bn from Rs 28.93 bn in the year-ago period. Sales in the Indian market saw a growth of 1% at Rs 5.9 bn. Sales in the US market fell to Rs 8.2 bn in the December quarter. Company's forex loss stood at Rs 1.3 bn this quarter compared to Rs 0.1 bn profit from the 2013 December quarter. Last year, the company had agreed to settle litigation related to its participation in Texas Medicaid, the US federal-state health care. The settlement deal was worth about US$ 40 m.

Banking stocks are trading weak with Union Bank and ICICI Bank being the leading pack of losers. However, HDFC Bank continues to trade strong. According to a leading financial daily, Yes bank has signed a pact with OPIC, a subsidiary of US government's development finance institution for US$ 220 m (Rs 13.5 bn) loan. The loan will be utilized to support the development of private sector, in particular micro, small and medium enterprises. The loan is for 12 years and the bank will draw it in one go. Overall, the micro-SME sector contributes about 40% to India's exports, and contributes about 35% to the country's GDP.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Stock markets extend losses". Click here!

  
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE BANKEX


Jul 21, 2017 (Close)

MARKET STATS